N-PEP-12 Cognitive Trial: What the 2026 Attention Study Found
A randomized, placebo-controlled 2026 study tested N-PEP-12 in 276 adults aged 50 to 75 with subjective cognitive complaints. The trial reported exploratory signals in attention, working memory, mood, and stress measures, but its primary statistical interpretation and proprietary composition require careful reading.





